Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Inhibition of Interleukin 6 Using Vamikibart for Treating Uveitic Macular Edema: Results from the Phase 1 DOVETAIL Study

  • By

  • Sumit Sharma

  • Phoebe Lin

  • Allen Hu

  • Eric B. Suhler

  • Meike Pauly-Evers

  • William Holmes

  • Zeinab Barekati

  • Daniela Willen

  • Lachlan Macgregor

  • Laura Steeples

  • Zdenka Haskova

  • Derrick Feenstra

  • David Silverman

  • Benedicte Passemard

  • Sascha Fauser

  • Marina Mesquida

  • May 1, 2026

Share

Original Source(s)

Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized

  • by Sumit Sharma, Phoebe Lin, Allen Hu, Eric B. Suhler, Meike Pauly-Evers, William Holmes, Zeinab Barekati, Daniela Willen, Lachlan Macgregor, Laura Steeples, Zdenka Haskova, Derrick Feenstra, David Silverman, Benedicte Passemard, Sascha Fauser, Marina Mesquida

  • May 1, 2026

Related Content

Equal Pay in Ophthalmology? Not Yet

A decade of AAMC salary data reveals a persistent gender pay gap in academic ophthalmology—and projects it will never close at senior ranks

Clinical Trial Update July/August 2026

Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.

  • July 1, 2026

  • 46 min
A Novel Technique for Uveitis

Dr. David Chin Yee describes the benefits of delivering XIPERE directly into the suprachoroidal space